More about

Hydrochlorothiazide

News
May 17, 2024
2 min read
Save

Similar outcomes seen with chlorthalidone, hydrochlorothiazide among veterans

LONG BEACH, Calif. — Progression toward chronic kidney disease was similar in a Veterans Affairs Health Care System study of patients on either chlorthalidone or hydrochlorothiazide, according to a study presented here.

News
November 19, 2023
3 min read
Save

Low-salt diet confers similar BP benefit to common first-line antihypertensive medication

PHILADELPHIA — Switching to a low-sodium diet conferred BP benefits similar to that of hydrochlorothiazide, a common first-line antihypertensive medication, a speaker reported.

News
September 11, 2023
1 min read
Save

SGLT2 inhibitors, hydrochlorothiazide lowered sympathetic nerve activity

SGLT2 inhibitors and hydrochlorothiazide both reduced muscle sympathetic nerve activity in patients with diabetes, but recent data show one of the therapies could lead to more weight loss and better glycemic control.

News
May 03, 2023
2 min read
Save

Hypertension treatment hydrochlorothiazide could increase skin cancer risks

Patients treated with hydrochlorothiazide for hypertension may face an increased risk for certain skin cancers with longer duration of use, according to a study.

News
April 11, 2023
2 min read
Save

Effectiveness of common blood pressure drugs varies widely

Blood pressure lowering with common antihypertension drugs varies widely among adults with hypertension, yet greater reductions are possible with personalized therapy, researchers reported.

News
March 06, 2023
2 min read
Save

Hydrochlorothiazide shows little improvement in kidney stone recurrence

The incidence of kidney stone recurrence did not significantly differ among patients who received hydrochlorothiazide compared with those who received placebo, according to a study published in The New England Journal of Medicine.

News
November 06, 2022
4 min watch
Save

VIDEO: Takeaways from AHA 2022 with Manesh R. Patel, MD, FACC, FAHA, FSCAI

CHICAGO — In this Healio exclusive, Manesh R. Patel, MD, FACC, FAHA, FSCAI, provides his perspective on a few of the late-breaking clinical trials presented at the American Heart Association Scientific Sessions.

News
November 05, 2022
2 min read
Save

No difference in CV outcomes with two common diuretics among veterans with hypertension

CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.

News
October 06, 2022
3 min read
Save

AHA announces late-breaking science lineup to be presented at 2022 Scientific Sessions

The American Heart Association Scientific Sessions will be held live in Chicago and can be attended virtually Nov. 5 to 7, and will feature nine late-breaking science sessions over 3 days.

News
April 27, 2022
1 min read
Save

Pfizer voluntarily recalls five more lots of BP medication for carcinogen risk

Pfizer issued a voluntarily nationwide recall of five lots of quinapril HCl/hydrochlorothiazide tablets due to the presence of a nitrosamine known to be carcinogenic in high doses.

View more